Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes

Abstract

Introduction My Dose Coach (MDC) is a US Food and Drug Administration-approved digital smartphone application designed to help users with type 2 diabetes (T2D) titrate their basal insulin (BI) according to a clinician-prescribed individualized titration plan. The aim of this analysis was to assess the impact of the frequency of MDC use on clinical outcomes. Methods This retrospective observational analysis included people with T2D who were registered for MDC (August 1st, 2018–April 30th, 2020) and received BI. Users with an activated care plan and ≥2 fasting blood glucose (FBG) observations spanning ≥2 weeks were defined as active. Outcomes included percentage achieving their individual FBG target, time to FBG target, change in FBG, change in insulin dose and hypoglycemia. Users were stratified into high (>3 days per week), moderate (>1– ≤3 days per week), and low (≤1 day per week) MDC usage groups. Results The analysis included 2517 active MDC users. Approximately 49% of users had high MDC usage. Overall, 44% of users across all usage frequencies achieved their individual FBG target. High MDC use was associated with significantly better FBG target achievement and less time to FBG target versus moderate- and low-usage groups ( p ≤0.01 for all). Insulin dose change was significantly greater in the high- versus moderate-usage group ( p =0.01). There was no significant difference in hypoglycemia incidence among MDC usage groups (12%–16% of users in any usage group). Conclusions More frequent MDC usage was associated with better FBG outcomes without increased hypoglycemia risk. Supplementary Information The online version contains supplementary material available at 10.1007/s13300-022-01245-9.

U-shaped association between online information exchange and app usage frequency: a large-scale survey of China ‘s online young and middle-aged people with pre diabetes and diabetes

“…There is growing evidence that online information exchange and regular app use play an important role in blood glucose control and daily blood glucose management, and these factors have become the focus of online users for blood glucose management (30,(39)(40)(41). We can see a statistically significant difference in app usage frequency in accordance with the extent of online information exchange, and this is the first large-scale study to our knowledge to explore the connection between information exchange and app usage among Chinese internet users.…”

“…According to our knowledge, whether participants have health difficulties or the app has numerous virtual or actual incentives, they are more likely to use it (27). As the frequency of online engagement rises, the behavior of users in day-to-day management may shift (28), while more frequency app usage correlates with better health habits and more normal blood sugar levels (29, 30), without increasing the risk of hypoglycemia (30). Since the app usage frequency is influenced by numerous variables and swings over time (27), it is difficult to maintain a high frequency of use (25,26).…”

“…Due to the significant relationship between the frequency of app use and daily blood glucose management (30), in order to effectively manage blood glucose, we need to improve the frequency of app use and create interventions to enhance the frequency of app use. According to recent research, apps with real-time information exchange capabilities can better follow online trends (31).…”

Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes

“…Historically, most of these tools have focused on diabetes education and medication reminders, but there is an increasing number of apps and devices that provide real-time decision support for insulin self-titration. 23 , 24 , 25 , 26 , 27 Work is ongoing to develop and validate effective digital health tools in this space.…”

Insights into the Feasibility and Acceptability of a Mobile Insulin Titration Application in Clinical Practice and Its Effects on Diabetes Outcomes

“… 7 While efforts are underway to expand the pool of HCPs who can provide these services, such healthcare challenges may lead to delayed initiation, inadequate titration and failure to adhere to prescribed basal insulin dosing in patients who require basal insulin therapy. 8 – 11 Insulin dosage adjustments are carried out at irregular intervals during busy clinical visits, resulting in patients often being under dosed thereby jeopardizing improved glycaemic outcomes. 12 …”